Search - tctmd.com

Displaying 361 - 380 of 989

Sort: Relevancy | Date

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

Shelley Wood

August 30, 2020

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

Shelley Wood

August 24, 2020

News Daily News

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Todd Neale

July 31, 2020

News Daily News

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Shelley Wood

July 24, 2020

News Daily News

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

Caitlin E. Cox

July 22, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Azithromycin Again Linked to Higher CV Mortality Risk

Caitlin E. Cox

June 23, 2020

News Daily News

Various Arrythmia Risk-Assessment Tools Streamlined in Multisociety Consensus

Todd Neale

June 22, 2020

News Daily News

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Caitlin E. Cox

June 15, 2020

News Daily News

COVID-19-Related Inflammatory Syndrome in Kids Needs Cardiac Follow-up

Shelley Wood

June 10, 2020

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

L.A. McKeown

June 04, 2020

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Shelley Wood

May 11, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

Advertisement

Implantation Technique Influences LV Remodeling After TMVR

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Super-Responders in COAPT: Improving MR and QoL Is Key

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Azithromycin Again Linked to Higher CV Mortality Risk

Various Arrythmia Risk-Assessment Tools Streamlined in Multisociety Consensus

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

COVID-19-Related Inflammatory Syndrome in Kids Needs Cardiac Follow-up

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content